Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre

Completed

• Conditions: Solid Tumor

• Registration Number: NCT01415258
• Lead Sponsor: Centre Oscar Lambret

Brief Summary

The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13).

The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-03
• Primary Completion: 2011-08
• Study First Submitted: 2011-08-10
• Study First Submitted QC: 2011-08-10
• Study First Posted: 2011-08-11
• Study Completion: 2012-04
• Status Verified: 2012-05
• Last Update Submitted: 2012-05-15
• Last Update Posted: 2012-05-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 209

Inclusion Criteria

• patient aged ≥ 70
• coming for a first visit, whatever the purpose and the disease stage

Exclusion Criteria

• neglect or refusal to answer to the VES-13 test

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the Vulnerable Elders Survey score (VES-13)	Within 3 months after recruitment	A patient is identified vulnerable if the score is ≥ 3

Secondary Outcome Measures

Name	Time	Method
To assess the correlation between the VES-13 score and the vulnerability judged by a clinical expert	Within 3 months after recruitment	A patient will be identified as vulnerable if he/she belongs to the "intermediate" or "frail" category. The Kappa coefficient of agreement will be used to correlate the VES-13 score and clinical observations.
To measure the muscle strength using the grip strength test	Within 3 months after recruitment	Hand Dynamometer Range values : 0-90

Trial Locations

Locations (1)

Oscar Lambret Anti-Cancer Centre; 🇫🇷 Lille cedex, France